Monoclonal Antibodies in the Treatment of Non-Hodgkin???s Lymphoma

This publication has 84 references indexed in Scilit:

• Antibody Conjugates and Therapeutic Strategies
  Molecular Interventions, 2005
• Novel Immune-Based Treatment Strategies for Chronic Lymphocytic Leukemia
  Journal of Clinical Oncology, 2005
• Activity of selective fully human agonistic antibodies to the TRAIL death receptors TRAIL‐R1 and TRAIL‐R2 in primary and cultured lymphoma cells: induction of apoptosis and enhancement of doxorubicin‐ and bortezomib‐induced cell death
  British Journal of Haematology, 2005
• HGS-ETR1, a fully human TRAIL-receptor 1 monoclonal antibody, induces cell death in multiple tumour types in vitro and in vivo
  British Journal of Cancer, 2005
• ¹³¹I-Tositumomab Therapy as Initial Treatment for Follicular Lymphoma
  New England Journal of Medicine, 2005
• The biology of VEGF and its receptors
  Nature Medicine, 2003
• Targeting death and decoy receptors of the tumour-necrosis factor superfamily
  Nature Reviews Cancer, 2002
• Problems of Delivery of Monoclonal Antibodies
  Clinical Pharmacokinetics, 1995
• The B7 and CD28 receptor families
  Immunology Today, 1994
• Humanized antibodies
  Immunology Today, 1993